Related Experiment Video

Updated: May 18, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases

G Siegel1, E Ermilov

  • 1Charité - University Clinic Berlin, D-14195 Berlin, Germany. guenter.siegel@charite.de

Atherosclerosis
|October 4, 2012
PubMed

Insights

Omega-3 fatty acids, specifically DHA and EPA, are crucial for distinguishing between patients with and without intracranial artery stenosis (ICAS). Lower DHA levels in phospholipids correlate with increased ICAS risk, highlighting their role in stroke prevention.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cardiology

Background:

  • Intracranial artery stenosis (ICAS) is a significant cause of ischemic stroke.
  • Long-chain omega-3 fatty acids, such as DHA and EPA, play a role in cardio-cerebro-vascular diseases (CCVDs) and Alzheimer's dementia (AD).

Purpose of the Study:

  • To review the discrimination between non-stroke controls and ischemic stroke patients based on phospholipid omega-3 fatty acid composition.
  • To discuss the general effects of omega-3 polyunsaturated fatty acids (PUFAs) in CCVDs and AD.

Main Methods:

  • Commentary and review of existing literature.
  • Analysis of phospholipid fatty acid composition, specifically DHA and EPA.
  • Correlation analysis between DHA levels and ICAS risk.

Main Results:

  • DHA and EPA are important biomarkers for differentiating between no cerebral arteriosclerotic stenosis (NCAS) and ICAS.
  • The risk of ICAS is inversely correlated with the phospholipid DHA content.
  • Mechanistic explanations for PUFA benefits in CCVDs and AD have been proposed.

Conclusions:

  • The beneficial effects of EPA/DHA for cardiovascular diseases and stroke are well-established.
  • Preventive effects in early Alzheimer's disease require confirmation through larger clinical trials.
  • International collaboration and cautiously designed studies are needed to further investigate these effects.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...